Transient cholestasis during treatment with ajmaline, and chronic xanthomatous cholestasis after administration of ajmaline, methyltestosterone and ethinylestradiol. Two case reports.
D000208:Acute Disease; D000404:Ajmaline / Q000009:adverse effects; D001653:Bile Ducts, Intrahepatic / Q000503:physiopathology; D001663:Bilirubin / Q000097:blood; D002779:Cholestasis / Q000139:chemically induced*; D002908:Chronic Disease; D004357:Drug Synergism; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D008777:Methyltestosterone / Q000009:adverse effects* / Q000378:metabolism; D008854:Microscopy, Electron; D008875:Middle Aged; D012157:Mononuclear Phagocyte System / Q000503:physiopathology; D010946:Plants, Medicinal; D011926:Rauwolfia / Q000009:adverse effects*
D000404:Ajmaline; D004997:Ethinyl Estradiol; D001663:Bilirubin; D008777:Methyltestosterone